Atherosclerosis
Volume 186, Issue 1 , Pages 12-19 , May 2006

Phytosterols and vascular disease

Received 13 October 2005 ,Accepted 13 October 2005.

References 

  1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) . Lancet. 1994;344:1383–1389
  2. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301–1307
  3. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999;341:410–418
  4. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565
  5. Lichtenstein AH, Deckelbaum RJ. AHA Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels. A statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation. 2001;103:1177–1179
  6. Normen L, Dutta P, Lia A, Andersson H. Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. Am J Clin Nut. 2000;71:908–913
  7. Jones PJ, Ntanios FY, Raeini-Sarjaz M, Vanstone CA. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am J Clin Nut. 1999;69:1144–1150
  8. Peterson DW. Effect of soybean sterols in the diet on plasma and liver cholesterol in chicks. Proc Soc Exp Biol Med. 1951;78:143–147
  9. Salen G, Horak I, Rothkopf M, et al. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res. 1985;26:1126–1133
  10. Sudhop T, Lutjohann D, Kodal A, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation. 2002;106:1943–1948
  11. Salen G, von Bergmann K, Lutjohann D, et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation. 2004;109:966–971
  12. Ling WH, Jones PJ. Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci. 1995;57:195–206
  13. Weihrauch JL, Gardner JM. Sterol content of foods of plant origin. J Am Diet Assoc. 1978;73:39–47
  14. Normen L, Johnsson M, Andersson H, van Gameren Y, Dutta P. Plant sterols in veges and fruits commonly consumed in Sweden. Eur J Nut. 1999;38:84–89
  15. Salen G, Kwiterovich PO, Shefer S, et al. Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis. J Lipid Res. 1985;26:203–209
  16. Lutjohann D, Bjorkhem I, Ose L. Phytosterolaemia in a Norwegian family: diagnosis and characterization of the first Scandinavian case. Scand J Clin Lab Invest. 1996;56:229–240
  17. Eneroth P, Hellstrom K, Ryhage R. Identification of two neutral metabolites of stigmasterol found in human feces. Bile acids and sterols I62. Steroids. 1965;6:707–720
  18. McNamara DJ, Proia A, Miettinen TA. Thin-layer and gas–liquid chromatographic identification of neutral steroids in human and rat feces. J Lipid Res. 1981;22:474–484
  19. Eneroth P, Hellstroem K, Ryhage R. Identification and quantification of neutral fecal steroids by gas–liquid chromatography and mass spectometry: studies of human excretion during two dietary regimens. J Lipid Res. 1964;41:245–262
  20. Salen G, Ahrens EH, Grundy SM. Metabolism of beta-sitosterol in man. J Clin Invest. 1970;49:952–967
  21. Andersson SW, Skinner J, Ellegard L, et al. Intake of dietary plant sterols is inversely related to serum cholesterol concentration in men and women in the EPIC Norfolk population: a cross-sectional study. Eur J Clin Nutr. 2004;58:1378–1385
  22. Valsta LM, Lemstrom A, Ovaskainen ML, et al. Estimation of plant sterol and cholesterol intake in Finland: quality of new values and their effect on intake. Br J Nutr. 2004;92:671–678
  23. Kudchodkar BJ, Sodhi HS, Horlick L. Absorption of dietary cholesterol in man. Metabolism. 1973;22:155–163
  24. Gould RG, Jones RJ, LeRoy GV, Wissler RW, Taylor CB. Absorbability of beta-sitosterol in humans. Metabolism. 1969;18:652–662
  25. Ostlund RE, McGill JB, Zeng CM, et al. Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab. 2002;282:E911–E916
  26. Heinemann T, Axtmann G, von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest. 1993;23:827–831
  27. Hidaka H, Nakamura T, Aoki T, et al. Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis. J Lipid Res. 1990;31:881–888
  28. Altmann SW, Davis HR, Zhu LJ, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004;303:1201–1204
  29. Yu L, Hammer RE, Li-Hawkins J, et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA. 2002;99:16237–16242
  30. Ikeda I, Sugano M. Inhibition of cholesterol absorption by plant sterols for mass intervention. Curr Opin Lipidol. 1998;9:527–531
  31. Subbiah R. Significance of dietary plant sterols in man and experintal animal. Mayo Clin Proc. 1971;46:549–559
  32. Katan MB, Grundy SM, Jones P, et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003;78:965–978
  33. Lees RS, Lees AM. Effects of sitosterol on plasma lipid and lipoprotein concentration. Lipoprotein Metab. 1976;119–130
  34. Blair SN, Capuzzi DM, Gottlieb SO, et al. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol. 2000;86:46–52
  35. Vanhanen HT, Blomqvist S, Ehnholm C, et al. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res. 1993;34:1535–1544
  36. Geelen A, Zock PL, de Vries JH, Katan MB. Apolipoprotein E polymorphism and serum lipid response to plant sterols in humans. Eur J Clin Invest. 2002;32:738–742
  37. Bhattacharyya AK, Connor WE. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest. 1974;53:1033–1043
  38. Lutjohann D, Bjorkhem I, Beil UF, von Bergmann K. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J Lipid Res. 1995;36:1763–1773
  39. Watts GF, Mitchell WD. Clinical and metabolic findings in a patient with phytosterolaemia. Ann Clin Biochem. 1992;29(Part 2):
  40. Mymin D, Wang J, Frohlich J, Hegele RA. Image in cardiovascular medicine. Aortic xanthomatosis with coronary ostial occlusion in a child homozygous for a nonsense mutation in ABCG8. Circulation. 2003;107:791
  41. Salen G, Shefer S, Nguyen L, et al. Sitosterolemia. J Lipid Res. 1992;33:945–955
  42. Miettinen TA. Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur J Clin Invest. 1980;10:27–35
  43. Bjorkhem I, Boberg KM. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: 7th ed.. The metaboilic basis of inherited disese. vol 2:McGraw-Hill Inc.; 2004;p. 2073–2102
  44. Belamarich PF, Deckelbaum RJ, Starc TJ, et al. Response to diet and cholestyramine in a patient with sitosterolemia. Pediatrics. 1990;86:977–981
  45. Malini T, Vanithakumari G. Antifertility effects of beta-sitosterol in male albino rats. J Ethnopharmacol. 1991;35:149–153
  46. Malini T, Vanithakumari G. Effect of beta-sitosterol on uterine biochemistry: a comparative study with estradiol and progesterone. Biochem Mol Biol Int. 1993;31:659–668
  47. Mellanen P, Petanen T, Lehtimaki J, et al. Wood-derived estrogens: studies in vitro with breast cancer cell lines and in vivo in trout. Toxicol Appl Pharmacol. 1996;136:381–388
  48. Patel SB, Salen G, Hidaka H, et al. Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. J Clin Invest. 1998;102:1041–1044
  49. Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000;290:1771–1775
  50. Lu K, Lee MH, Hazard S, et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet. 2001;69:278–290
  51. Berge KE. Sitosterolemia: a gateway to new knowledge about cholesterol metabolism. Ann Med. 2003;35:502–511
  52. Salen G, Shore V, Tint GS, et al. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J Lipid Res. 1989;30:1319–1330
  53. Salen G, Tint GS, Shefer S, Shore V, Nguyen L. Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia. Arterioscler Thromb. 1992;12:563–568
  54. Nguyen LB, Shefer S, Salen G, et al. A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis. J Clin Invest. 1990;86:923–931
  55. Nguyen LB, Salen G, Shefer S, Tint GS, Ruiz F. Macrophage 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in sitosterolemia: effects of increased cellular cholesterol and sitosterol concentrations. Metabolism. 2001;50:1224–1229
  56. Khachadurian AK, Clancy KF. Familial phytosterolemia: report of five cases and studies in cultured fibroblasts. Clin Res. 2004;26:329A
  57. Shefer S, Salen G, Bullock J, et al. The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7 alpha-hydroxylase in the rat and sitosterolemic homozygotes. Hepatology. 1994;20:213–219
  58. Shefer S, Hauser S, Lapar V, Mosbach EH. Regulatory effects of sterols and bile acids on hepatic 3-hydroxy-3-methylglutaryl CoA reductase and cholesterol 7alpha-hydroxylase in the rat. J Lipid Res. 1973;14:573–580
  59. Morganroth J, Levy RI, McMahon AE, Gotto AM. Pseudohomozygous type II hyperlipoproteinemia. J Pediatr. 1974;85:639–643
  60. Miettinen TA, Gylling H, Lindbohm N, Miettinen TE, Rajaratnam RA, Relas H. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. J Lab Clin Med. 2003;141:131–137
  61. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M, Milla PJ. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology. 1993;105:1806–1813
  62. Nguyen LB, Cobb M, Shefer S, Salen G, Ness GC, Tint GS. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction. J Lipid Res. 1991;32:1941–1948
  63. Jurado J, Seip R, Thompson PD. Effectiveness of ezetimibe in clinical practice. Am J Cardiol. 2004;93:641–643
  64. Cobb MM, Salen G, Tint GS, Greenspan J, Nguyen LB. Sitosterolemia: opposing effects of cholestyramine and lovastatin on plasma sterol levels in a homozygous girl and her heterozygous father. Metabolism. 1996;45:673–679
  65. Berge KE, von Bergmann K, Lutjohann D, et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res. 2002;43:486–494
  66. Glueck CJ, Speirs J, Tracy T, et al. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism. 1991;40:842–848
  67. Sudhop T, Gottwald BM, von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism. 2002;51:1519–1521
  68. Assman G, Cullen P. Elevation in plasma sitosterol concentration is associated with an increased risk for coronary events in the PROCAM study. Suppl IV Circ. 2003;108:730
  69. Mellies MJ, Ishikawa TT, Glueck CJ, Bove K, Morrison J. Phytosterols in aortic tissue in adults and infants. J Lab Clin Med. 1976;88:914–921
  70. Salonen JT, Nyyssonen K, Salonen R, et al. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation. 1997;95:840–845
  71. Zieden B, Kaminskas A, Kristenson M, et al. Increased plasma 7 beta-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease. Arterioscler Thromb Vasc Biol. 1999;19:967–971
  72. Plat J, Brzezinka H, Lutjohann D, Mensink RP, von Bergmann K. Oxidized plant sterols in human serum and lipid infusions as measured by combined gas–liquid chromatography–mass spectrometry. J Lipid Res. 2001;42:2030–2038
  73. Anttolainen M, Luoto R, Uutela A, et al. Characteristics of users and nonusers of plant stanol ester margarine in Finland: an approach to study functional foods. J Am Diet Assoc. 2001;101:1365–1368
  74. Wilund KR, Yu L, Xu F, et al. No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterioscler Thromb Vasc Biol. 2004;24:2326–2332

PII: S0021-9150(05)00673-8

doi: 10.1016/j.atherosclerosis.2005.10.026

Atherosclerosis
Volume 186, Issue 1 , Pages 12-19 , May 2006

Article Tools

* Image Usage & Resolution